How will Pharmaniaga ensure uninterrupted supply of over 700 products?

Question

Accepted Answer

Pharmaniaga Assures Continuous Supply of Over 700 Products to Health Ministry Facilities

Pharmaniaga Bhd has given its assurance to the government regarding the uninterrupted supply of more than 700 drug and non-drug products to all Health Ministry (MOH) facilities. This commitment was reiterated during a meeting with the Health Ministry, where Pharmaniaga, alongside industry representatives from the Malaysian Organisation of Pharmaceutical Industries (MOPI) and the Pharmaceutical Association of Malaysia (PhAMA), discussed measures to maintain supply chain integrity. The discussions also served to clarify recent allegations concerning delayed payments by Pharmaniaga to its principals.
Commitment to Competitiveness and Supply Chain Stability

Pharmaniaga conveyed its dedication to remaining a strong and competitive entity during a meeting with the Health Ministry. This assurance directly addresses concerns that may arise from the company's financial status, particularly its PN17 classification. The focus remains on ensuring that the supply of essential medical products to government facilities is not compromised.
Collaborative Effort with Industry Associations

Both MOPI and PhAMA have pledged their full cooperation to ensure the drug and non-drug supply chain remains unaffected. This collaborative approach signifies a united front among key stakeholders in the pharmaceutical sector to mitigate any potential disruptions and uphold the consistent delivery of healthcare provisions.
Clarification on Payment Allegations

The meeting provided an opportunity to address and clarify allegations that Pharmaniaga has experienced delays in payments to pharmaceutical companies and medical device companies. Understanding and resolving these financial matters is crucial for maintaining confidence in the company's operational stability and its ability to meet its obligations to its partners.
Health Ministry's Oversight and Continued Engagement

The Health Ministry views the issue of Pharmaniaga's PN17 status with seriousness, acknowledging its potential impact on drug supply and repayment capabilities. The ministry stated its ongoing commitment to working collaboratively with all relevant parties to ensure that the delivery of health services to the public continues at an optimal level, safeguarding the well-being of all Malaysians.

Reading history

Hide →

This history is cleared when the page is closed.

How will Pharmaniaga ensure uninterrupted supply of over 700 products?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends